<code id='B44226F0D0'></code><style id='B44226F0D0'></style>
    • <acronym id='B44226F0D0'></acronym>
      <center id='B44226F0D0'><center id='B44226F0D0'><tfoot id='B44226F0D0'></tfoot></center><abbr id='B44226F0D0'><dir id='B44226F0D0'><tfoot id='B44226F0D0'></tfoot><noframes id='B44226F0D0'>

    • <optgroup id='B44226F0D0'><strike id='B44226F0D0'><sup id='B44226F0D0'></sup></strike><code id='B44226F0D0'></code></optgroup>
        1. <b id='B44226F0D0'><label id='B44226F0D0'><select id='B44226F0D0'><dt id='B44226F0D0'><span id='B44226F0D0'></span></dt></select></label></b><u id='B44226F0D0'></u>
          <i id='B44226F0D0'><strike id='B44226F0D0'><tt id='B44226F0D0'><pre id='B44226F0D0'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:5
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Big Tobacco's 'harm reduction': Is it for real, or a sham?
          Big Tobacco's 'harm reduction': Is it for real, or a sham?

          TOLGAAKMEN/AFP/GettyImagesThisyearcouldshapeuptobeahistoriconefortobaccocontrol—oroneinwhichBigTobac

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo